Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes

Published:2016-02-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hutzschenreuter Franz¹,Monsef Ina¹,Kreuzer Karl-Anton²,Engert Andreas²,Skoetz Nicole¹

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Cologne Germany

2. University Hospital of Cologne; Department I of Internal Medicine; Cologne Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference96 articles.

1. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study;Balleari;Annals of Hematology,2006

2. Phase III randomized multicenter trial of G-CSF vs. observation for myelodysplastic syndromes (MDS);Greenberg;Blood,1993

3. Long term treatment of intermediate risk myelodysplastic syndromes with rhG-CSF and rhEPO: interim report of an ongoing randomized phase III trial;Mantovani;Annals of Hematology,1996

4. Randomized Phase II study on the value of G-CSF (Filgrastim) in combination with standard induction chemotherapy in myelodysplastic syndromes (MDS);Ossenkoppele;Blood,1995

5. A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative Group;Ossenkoppele;Leukemia,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deregulation of New Cell Death Mechanisms in Leukemia;Cancers;2024-04-25

2. Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS);Current Oncology;2023-06-27

3. Supportive Care for Patients With Myelodysplastic Syndromes;The Cancer Journal;2023-05

4. Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes;Current Treatment Options in Oncology;2023-03-25

5. Stimulation of B-Lymphopoiesis by Administration of a Trimecaine-Based Ionic Compound in Cyclophosphamide-Induced Hematopoietic-Depressive Model;Molecules;2023-02-01